Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

that exclude CNS sales.

About drugstore.com, inc.

drugstore.com, inc. (NASDAQ: DSCM) is a leading online provider of health, beauty, vision, and pharmacy products. Our portfolio of brands includes: drugstore.com(TM), Beauty.com(TM) and VisionDirect.com(TM). All are accessible from http://www.drugstore.com and provide a convenient, private, and informative shopping experience while offering a wide assortment of more than 30,000 products at competitive prices.

The drugstore.com pharmacy is certified by the National Association of Boards of Pharmacy (NABP) as a Verified Internet Pharmacy Practice Site (VIPPS) and operates in compliance with federal and state laws and regulations in the United States.

The financial results contained in this press release are preliminary and unaudited. In addition, this press release contains forward-looking statements regarding future events or the future financial and operational performance of drugstore.com, inc. Words such as "target," "expect," "believe," "may," "will," "focus," "continue," "would," "should," and similar expressions, are intended to identify forward-looking statements. Forward-looking statements are based on current expectations, are not guarantees of future performance and involve assumptions, risks, and uncertainties. Actual performance may differ materially from those contained or implied in such forward-looking statements. Risks and uncertainties that could lead to such differences could include, among other things: effects of changes in the economy, changes in consumer spending, fluctuations in the stock market, changes affecting the Internet, online retailing and advertising, difficulties establishing our bra
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...igher mortality and lower surgery rates in women v...akage may be related to the complexity of evaluati... findings of a Mayo Clinic study published this mo...al valve prolapse affects approximately 150 millio...ery, preferably valve repair rather than replaceme...
(Date:12/1/2008)...HICON, Inc., a Johnson & Johnson company, anno...of its Professional Wound Care business to One Equ...are not being disclosed. , , Under the term...ired the Professional Wound Care product portfolio...s PROMOGRAN Matrix Wound Dressing, TIELLE Hydropol...
(Date:12/1/2008)...itute,s cancer registry has found that as many as ...mplete radiation treatment following breast-conser...ad to worse outcomes. , Dr. Heather Taffet Gold ...und that among a nationally representative sample ...ed 65 and older, almost 1,300 women experienced de...
(Date:12/1/2008)... -- The Food Allergy & Anaphylaxis Network (FA...ew CEO, replacing Founder Anne Munoz-Furlong, who ...N extensive knowledge of anaphylaxis, a severe, po...x years, as Senior Director of Marketing, she led ...Dey Pharmaceutical products, including EpiPen(R), ...
Breaking Medicine News(10 mins):Health News:Women with mitral valve prolapse are treated less aggressively than men and may be at high risk 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:FAAN Names New CEO 2
...rnataka insist on a HIV certificate from the forei...datory//. The Visvesvaraya Technological Universit...eges in the state. It has issued strict orders no.../NRI students during admissions. K Balaveera Reddy...
...s have said that they planned to begin restocking ... Livestock Breeding and Veterinary department in ...u as also the subsequent culling program would be ...oultry feed, while keeping such areas under close ...
... have issued a warning to the public that they cou...rescription drugs through the Internet//. Drugs ... from foreign websites, have often turned out to.... Nigel Strick, the council's trading standards ma...
...d on Thursday in favour of a group of South Africa...partment// must immediately remove restrictions on...ment for the prisoners. The case was brought on b...a Gabriel, who represented the prisoners and the T...
Other Medicine News:
(Date:12/1/2008)...IANAPOLIS, Dec. 1 Roche announced ...ate differences in perceived pain and,discomfort ...CHEK blood,glucose monitoring systems and lancing...ts indicated that, overall, the ACCU-CHEK Aviva an... systems and the ACCU-CHEK Multiclix, ACCU-CHEK,S...
(Date:12/1/2008)...MOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ ...nounced that dosing of subjects has begun in study... dose Phase 1b study of trodusquemine (MSI-1436) i...is a novel therapeutic for the treatment of type 2...ripherally to regulate insulin and leptin pathways...
(Date:12/1/2008)... DIEGO, Dec. 1 Vical Inc...ceipt of a $1.0 million milestone payment from Mer...tion of a Phase I clinical trial of an investigati...ate vaccine is based on Vical,s DNA gene delivery ...anscriptase (hTERT). hTERT is the subject of separ...
(Date:11/28/2008)...IANAPOLIS, Nov. 28 Eli L... supplemental New Drug Application (sNDA) from,th...alta(R) (duloxetine HCl),for the management of ch...n in,the first half of 2009, adding data from a r...arthritis pain of the knee. , The decision ...
Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 1Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 2Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 3Announcing Prime Vendor Contract with LIHPA 7310 1Announcing Prime Vendor Contract with LIHPA 7310 2Diets May Raise Cancer Risk for Poor Urban Women 7307 1Diets May Raise Cancer Risk for Poor Urban Women 7307 2SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution 7305 1SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution 7305 2
... Nuvion Antibody Led to a Sustained Response and R...dies and Was Adequately,Tolerated in Patients with..., Calif., May 22, 2007 /PRNewswire-FirstCall/ -- D...meeting this week in,Washington D.C. by Dr. Willia...n (visilizumab), an antibody in development as a,t...
... ANN ARBOR, Mich., May 22, 2007 /PRNewswire/ -- N...veloping novel products,for the treatment and prev...tive safety data from its Phase 1 clinical study o...n a Phase 2,clinical trial for the topical treatme...was completed in January 2007 and,involved 20 subj...
Other Medicine Technology:PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 2NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 3
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: